Radiopharmacueticals, department of radiology nuclear medicine

Ended Purchase Order Awarded Last action

Contract number
W81K0025PA273
Awardee
Awarding agency
Obligated
$58,006

Award facts

Contract value 100% obligated
$58,006.25 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Lake Mary, FL 32746, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00003 $0
Funding Only Action P00002 $58,006
Other Administrative Action P00001 $0
Original award $0

About this award

The Defense Health Agency awarded a purchase order to RLS (USA) Inc. on October 1, 2025, with a ceiling value of $58,006.25 for radiopharmaceuticals supporting the Department of Radiology Nuclear Medicine. No set-aside was used, and RLS (USA) Inc. does not hold small business designations. The order is firm fixed price, with performance in Lake Mary, Florida 32746. The ultimate completion date was September 30, 2026.

Quick answers

Who was awarded contract W81K0025PA273?

W81K0025PA273 was awarded to RLS (USA) Inc. by Medical Command (Department of the Army) on October 1, 2025.

How much is contract W81K0025PA273 worth?

The government has obligated $58,006 on W81K0025PA273.

Which agency awarded contract W81K0025PA273?

Medical Command (Department of the Army) awarded W81K0025PA273, with funding from Defense Health Agency (Department of Defense).

Was contract W81K0025PA273 competed?

The extent of competition for W81K0025PA273 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award